What is hemophagocytic lymphohistiocytosis (HLH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is HLH (Hemophagocytic Lymphohistiocytosis)?

HLH is a life-threatening hyperinflammatory syndrome caused by uncontrolled activation of macrophages and cytotoxic T cells, leading to excessive cytokine release, end-organ damage, and death without immunosuppressive treatment. 1

Core Pathophysiology

HLH represents an excessive but ineffective immune response characterized by:

  • Aberrant activation of CD8+ T cells and natural killer (NK) cells that fail to properly eliminate target cells
  • Rampant cytokine secretion creating a self-sustaining inflammatory cascade, particularly driven by interferon-γ 2
  • Macrophage hyperactivation leading to hemophagocytosis (macrophages engulfing blood cells)
  • Multi-organ dysfunction from unchecked inflammation that rapidly progresses to terminal organ failure 1, 2

Two Major Forms

Primary (Genetic) HLH

  • Most common in children but can occur in adolescents and young adults 1
  • Caused by bi-allelic germline mutations in genes essential for cytotoxic granule function: PRF1, UNC13D, STX11, STXBP2 2
  • Results in markedly reduced or absent CD8 T-cell and NK-cell killing ability 2
  • These genetic defects prevent proper formation and release of cytolytic granules needed to eliminate infected or abnormal cells

Secondary (Acquired) HLH

  • By far the most common form in adults 1
  • Triggered by strong immunological stimuli including:
    • Infections (viral, bacterial, fungal, parasitic)
    • Malignancies (particularly lymphomas and leukemias)
    • Autoimmune/autoinflammatory diseases (called Macrophage Activation Syndrome or MAS-HLH in this context) 1
    • Medications (including chemotherapy) 3
  • Patients generally lack bi-allelic mutations in primary HLH genes 2

Clinical Presentation

Patients present with a sepsis-like syndrome that can be indistinguishable from sepsis or multiple organ dysfunction syndrome 1. Key features include:

  • Persistent high fever (recurrent, unremitting)
  • Cytopenias (low blood cell counts affecting multiple cell lines)
  • Hepatosplenomegaly (enlarged liver and spleen)
  • Liver dysfunction with elevated aminotransferases
  • Coagulopathy (bleeding disorders)
  • Neurological impairment (can occur) 3
  • Rapid progression to multi-organ failure if untreated 1, 4

Laboratory Hallmarks

  • Marked hyperferritinemia (often >10,000 µg/L) 5
  • Hypertriglyceridemia
  • Hypofibrinogenemia
  • Elevated lactate dehydrogenase
  • Bicytopenia or pancytopenia 1, 5

Critical Clinical Pitfall

The most dangerous pitfall is mistaking HLH for sepsis alone. Both present with fever, organ dysfunction, and laboratory derangements. However, treating HLH as sepsis without addressing the hyperinflammation leads to continued deterioration and death 1. Early recognition is critical because irreversible organ damage occurs rapidly - this is a medical emergency requiring immediate immunosuppressive intervention 1, 4.

Diagnostic Challenge in Adults

The HLH-2004 diagnostic criteria were developed for children and are not validated for adults 1. The HScore is a validated tool specifically for estimating probability of secondary HLH in adults, with scores >220 indicating >93% probability 3. However, maintaining a high index of suspicion is more important than waiting for diagnostic criteria to be fully met when clinical presentation is consistent 1.

Prognosis Without Treatment

HLH is uniformly fatal without therapy directed at suppressing the overactive immune system 2, 6. Mortality remains high even with treatment, particularly in adults, making prompt recognition and aggressive management essential 4, 6.

Why Early Recognition Matters for Outcomes

Early intervention prevents irreversible organ damage and death 1. The hyperinflammatory cascade, once established, creates a positive feedback loop that becomes increasingly difficult to control. Delayed recognition allows progression to:

  • Irreversible multi-organ failure
  • Severe coagulopathy with life-threatening bleeding
  • Neurological damage
  • Death in the majority of untreated cases 4, 7

Related Questions

What are the types of hemophagocytic lymphohistiocytosis (HLH)?
In a 50‑year‑old patient with watery diarrhea, negative Clostridioides difficile test, elevated C‑reactive protein, abnormal liver function tests, pancytopenia, and markedly increased ferritin, should I consider secondary hemophagocytic lymphohistiocytosis (HLH)?
Could this 60-year-old man with necrotising fasciitis, candidemia, severe inflammation, acute kidney injury, anemia, thrombocytopenia, and low reticulocyte production index have secondary hemophagocytic lymphohistiocytosis (HLH)?
What is the breakdown of the medical terminology of hemophagocytic lymphohistiocytosis?
What is the comparison between dexamethasone and methylprednisolone in the treatment of Hemophagocytic Lymphohistiocytosis (HLH)?
In a patient admitted with complicated urinary tract infection, fever, and poorly controlled diabetes, who is receiving ceftriaxone and had a normal chest X‑ray on admission, now develops a cough on day 3–4 without fever or shortness of breath, should the antibiotic regimen be changed or an additional antibiotic added?
What is the diagnosis for a patient with a pituitary cyst and a prolactin level of approximately 184 ng/mL?
What is the prognosis and recommended treatment for autoimmune hepatitis in a 20-year-old male?
What are the non‑articular manifestations of hyperuricemia?
Should spironolactone be continued in a patient with hepatorenal syndrome presenting as acute kidney injury and massive ascites due to cirrhosis from chronic hepatitis B?
What are the standard surveillance definitions for hospital‑acquired infections, including HAI, CLABSI, CAUTI, VAP, SSI, and non‑line‑associated BSI?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.